Skip to Content
MilliporeSigma
All Photos(1)

Documents

Y0000199

Ciprofloxacin hydrochloride for peak identification

European Pharmacopoeia (EP) Reference Standard

Synonym(s):

Ciprofloxacin hydrochloride monohydrate

Sign Into View Organizational & Contract Pricing
All Photos(1)

About This Item

Empirical Formula (Hill Notation):
C17H18FN3O3 · HCl · H2O
CAS Number:
86393-32-0
Molecular Weight:
385.82
MDL number:
MFCD00242856
UNSPSC Code:
41116107
PubChem Substance ID:
329830881
NACRES:
NA.24

grade

pharmaceutical primary standard

API family

ciprofloxacin

manufacturer/tradename

EDQM

application(s)

pharmaceutical (small molecule)

format

neat

storage temp.

2-8°C

SMILES string

O.Cl.OC(=O)C1=CN(C2CC2)c3cc(N4CCNCC4)c(F)cc3C1=O

InChI

1S/C17H18FN3O3.ClH.H2O/c18-13-7-11-14(8-15(13)20-5-3-19-4-6-20)21(10-1-2-10)9-12(16(11)22)17(23)24;;/h7-10,19H,1-6H2,(H,23,24);1H;1H2

InChI key

ARPUHYJMCVWYCZ-UHFFFAOYSA-N

Looking for similar products? Visit Product Comparison Guide

Related Categories

General description

This product is provided as delivered and specified by the issuing Pharmacopoeia. All information provided in support of this product, including SDS and any product information leaflets have been developed and issued under the Authority of the Issuing Pharmacopoeia. For further information and support please go to the website of the issuing Pharmacopoeia.

Application

Ciprofloxacin hydrochloride for peak identification EP Reference standard, intended for use in laboratory tests only as specifically prescribed in the European Pharmacopoeia.

Packaging

The product is delivered as supplied by the issuing Pharmacopoeia. For the current unit quantity, please visit the EDQM reference substance catalogue.

Other Notes

Sales restrictions may apply.

related product

Product No.
Description
Pricing

PHR1044

Ciprofloxacin HCl, Pharmaceutical Secondary Standard; Certified Reference Material

PHR1167

Ciprofloxacin, Pharmaceutical Secondary Standard; Certified Reference Material

PHR1174

Fluoroquinolonic acid, Pharmaceutical Secondary Standard; Certified Reference Material

1134335

Ciprofloxacin hydrochloride, United States Pharmacopeia (USP) Reference Standard

1134324

Ciprofloxacin Ethylenediamine Analog, United States Pharmacopeia (USP) Reference Standard

1278302

Fluoroquinolonic acid, United States Pharmacopeia (USP) Reference Standard

C2190000

Ciprofloxacin hydrochloride, European Pharmacopoeia (EP) Reference Standard

C2190050

Ciprofloxacin impurity A, European Pharmacopoeia (EP) Reference Standard

1134459

Ciprofloxacin formamide, United States Pharmacopeia (USP) Reference Standard

1134346

Ciprofloxacin Related Compound A, United States Pharmacopeia (USP) Reference Standard

1134313

Ciprofloxacin, United States Pharmacopeia (USP) Reference Standard

BP930

Ciprofloxacin impurity standard, British Pharmacopoeia (BP) Reference Standard

wgk_germany

WGK 2

flash_point_f

Not applicable

flash_point_c

Not applicable

Choose from one of the most recent versions:

Certificates of Analysis (COA)

Lot/Batch Number

Sorry, we don't have COAs for this product available online at this time.

If you need assistance, please contact Customer Support.

Already Own This Product?

Find documentation for the products that you have recently purchased in the Document Library.

Visit the Document Library

Customers Also Viewed

Slide 1 of 6

1 of 6

vibrant-m

Y0001384

Fusidic acid impurity mixture

USP

USP

1134324

Ciprofloxacin Ethylenediamine Analog

7-Chloro-1-cyclopropyl-6-fluoro-1,4-dihydro-4-oxoquinoline-3-carboxylic acid 96%

Sigma-Aldrich

531901

7-Chloro-1-cyclopropyl-6-fluoro-1,4-dihydro-4-oxoquinoline-3-carboxylic acid

Ciprofloxacin United States Pharmacopeia (USP) Reference Standard

USP

1134313

Ciprofloxacin

Fluoroquinolonic acid Pharmaceutical Secondary Standard; Certified Reference Material

Supelco

PHR1174

Fluoroquinolonic acid

Ambroxol Hydrochloride Pharmaceutical Secondary Standard; Certified Reference Material

Supelco

PHR2063

Ambroxol Hydrochloride

Roles of the superoxide dismutase SodB and the catalase KatA in the antibiotic resistance of Campylobacter jejuni.
Sunyoung Hwang et al.
The Journal of antibiotics, 66(6), 351-353 (2013-04-04)
Kathryn E Holt et al.
Proceedings of the National Academy of Sciences of the United States of America, 110(43), 17522-17527 (2013-10-02)
Shigella sonnei is a human-adapted pathogen that is emerging globally as the dominant agent of bacterial dysentery. To investigate local establishment, we sequenced the genomes of 263 Vietnamese S. sonnei isolated over 15 y. Our data show that S. sonnei
E M Jones et al.
The Veterinary record, 173(17), 422-422 (2013-10-08)
Four models are presented investigating risks present on Great Britain (GB) turkey farms in breeding and fattening flocks for ciprofloxacin and cephalosporin resistance. Risk factors for ciprofloxacin resistance in fattening flocks were sourcing of feed from national compounders, antimicrobial use
Julie Papillon et al.
Nucleic acids research, 41(16), 7815-7827 (2013-06-28)
Type 2A DNA topoisomerases (Topo2A) remodel DNA topology during replication, transcription and chromosome segregation. These multisubunit enzymes catalyze the transport of a double-stranded DNA through a transient break formed in another duplex. The bacterial DNA gyrase, a target for broad-spectrum
Pieter Dewint et al.
Gut, 63(2), 292-299 (2013-03-26)
To assess whether a combination of adalimumab and ciprofloxacin is superior to adalimumab alone in the treatment of perianal fistulising Crohn's disease (CD). Randomised, double-blind, placebo controlled trial in eight Dutch hospitals. In total, 76 CD patients with active perianal
View All Related Papers

Our team of scientists has experience in all areas of research including Life Science, Material Science, Chemical Synthesis, Chromatography, Analytical and many others.

Contact Technical Service